Agenda 1 offers Lab Time Share service

Published: 3-Aug-2011

Supports all sizes of pharmaceutical company in the development of new products


Agenda 1 Analytical Services, a UK business spun out from the analytical laboratories of Nektar Therapeutics in Bradford, has developed Lab Time Share to support start-up pharmaceutical businesses and global organisations in the development and launch of new products.

The Lab Time Share concept provides expertise, lab space, high-end equipment and qualified staff to drug developers.

Kuecept, a drug development company in Potter’s Bar, Hertfordshire is using Agenda1’s facilities to apply new drug delivery technology to help clients progress their products into the clinic, working with nanoparticles, amorphous materials and drug solubisation technologies.

Kuecept development director Mark Saunders said: ‘Setting up dedicated lab space is very time consuming and comes with significant overheads. This can often be a rate-limiting step for anyone wanting to set up a new laboratory based business.

‘Initially the Lab Time Share scheme provided Kuecept with a fast route to market, allowing us to focus our efforts on our core business needs while still providing a top-class service to our clients.’

Available to organisations of all sizes, the Lab Time Share service allows customers to have as much or little direct control over their processes as they desire, ensuring the approach remains flexible and cost efficient.

Agenda 1 also has a number of segregated lab facilities, enabling processes and workers to be isolated where required.

Ian Siragher, managing director of Agenda 1, said: ‘Our aim is to facilitate the pharmaceutical process, in whatever way works for our customers, whether this be working alongside development scientists or engineers or handling the entire process ourselves.’

You may also like